Patent US4583611A successfully refreshed from Google Patents.
Patent US2451903A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4576592A Expired / Lapsed US ⏱️ 0.0 years remaining

Dual source parenteral infusion apparatus

Assignee: Fresenius SE and Co KGaA
•
Filing: 1983-03-30
•
Granted: 1986-03-18
•
Expires: 2003-03-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A dual parenteral solution apparatus for delivering predetermined volumes of two solutions at predetermined flow rates with increased accuracy. The apparatus has a shut-off valve in the supplementary solution supply system which is immediately activated when the supplemental solution supply is depleted.

Inventors

  • 👤 Hal C. Danby

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 16:05
CPC Classifications
A; A61; A61M; A61M5/00; A61M5/14; A61M5/168; A61M5/16804; A61M5/16827

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 115 words
A parenteral infusion apparatus for delivering parenteral solutions from two sources comprising a first drip chamber with a primary flow sensor means associated therewith for detecting liquid flow rate through the primary drip chamber, a supplemental solution drip chamber with supplemental solution flow sensor means associated therewith for detecting liquid flow rate through the supplemental solution drip chamber, the outlet of the supplemental solution drip chamber being connected with the primary drip chamber inlet by conduit means having a shut-off control system means associated therewith for terminating supplemental solution flow through the conduit when the measured flow detected in the supplemental solution drip chamber is less than the flow detected in the primary drip chamber.
Claim 2
Dependent Claim 115 words
A parenteral infusion apparatus for delivering parenteral solutions from two sources comprising a first drip chamber with a primary flow sensor means associated therewith for detecting liquid flow rate through the primary drip chamber, a supplemental solution drip chamber with supplemental solution flow sensor means associated therewith for detecting liquid flow rate through the supplemental solution drip chamber, the outlet of the supplemental solution drip chamber being connected with the primary drip chamber inlet by conduit means having a shut-off control system means associated therewith for terminating supplemental solution flow through the conduit when the measured flow detected in the supplemental solution drip chamber is less than the flow detected in the primary drip chamber.
Claim 3
Dependent Claim 20 words
The parenteral infusion apparatus of claim 1 wherein the supplemental solution drip chamber is remote from the primary drip chamber.
Claim 4
Dependent Claim 28 words
The parenteral infusion apparatus of claim 1 wherein the flow sensor means is a means for detecting passage of individual drops falling through the supplemental solution drip chamber.
Claim 5
Dependent Claim 48 words
The parenteral infusion apparatus of claim 3 wherein the supplemental solution flow sensor means comprises a light source for directing light through the path of drops falling in the supplemental solution drip chamber and a light collector means for focusing light transmitted through the supplemental solution drip chamber.
Claim 6
Dependent Claim 16 words
The parenteral infusion apparatus of claim 4 wherein the light is focused on a light sensor.
Claim 7
Dependent Claim 22 words
The parenteral infusion apparatus of claim 5 wherein the electrical signal from the light sensor is amplified and transmitted to a controller.
Claim 8
Dependent Claim 31 words
The parenteral infusion apparatus of claim 4 wherein the light is focused on the end of a fiber optics cable in optical communication with a light sensor means in a controller.
Claim 9
Dependent Claim 15 words
The parenteral infusion apparatus of claim 4 wherein the light source is a light-emitting diode.

References Cited (Backward Citations)

US3982534A Cited
US4094318A Cited
US4105028A Cited
US4261388A Cited
US4391598A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-03-17 1989-09-16 1990-03-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-03-17 1993-09-16 1994-03-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-03-17 1997-09-16 1998-03-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag